Dennis N. Berman is Director at Inhibikase Therapeutics, Inc. (IKT). They have made 1 open-market trade across 1 company since 2006, most recently 2026-07-30.
CIK 0001273858
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $12K since 2006, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| KNTA | BUY | 2006-05-18 | 2006-05-18 | $1.18 | $12K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.